Umoja wa Ulaya - Kislovenia - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - attenuated feline rhinotracheitis herpesvirus (fhv f2 strain), inactivated feline calicivirosis antigens (fcv 431 and g1 strains), attenuated chlamydophila felis (905 strain), attenuated feline panleucopenia virus (pli iv) - immunologicals za skupin felidae, - mačke - active immunisation of cats aged eight weeks and older:• against feline viral rhinotracheitis to reduce clinical signs;• against calicivirus infection to reduce clinical signs;• against chlamydophila felis infection to reduce clinical signs;• against feline panleucopenia to prevent mortality and clinical signs. nastopi imunosti so dokazali en teden po primarno cepljenje seveda za rhinotracheitis, calicivirus, chlamydophila felis in panleucopenia komponente. the duration of immunity is one year after the last re-vaccination for the chlamydiosis component, and oneyear after primary vaccination and three years after the last re-vaccination for the rhinotracheitis, calicivirosis and panleucopenia components.

Umoja wa Ulaya - Kislovenia - EMA (European Medicines Agency)

mcm vaccine b.v. - davica toxoid, tetanus toxoid, bordetella oslovskemu kašlju antigenov: oslovskemu kašlju toxoid, nitastih haemagglutinin, pertactin, fimbriae vrste 2 in 3, hepatitis b surface antigen, proizvedene v kvas celice, poliovirus (inaktivirano): tip 1 (mahoney), tip 2 (mef-1), tip 3 (saukett), ki v chicagu celic/ haemophilus influenzae tipa b polysaccharide (polyribosylribitol fosfat) konjugiran na meningococcal beljakovin. - meningitis, haemophilus; poliomyelitis; tetanus; diphtheria; whooping cough; hepatitis b - cepiva - vaxelis (dtap-hb-ipv-hib) je indicirano za osnovno in obnovitveno cepljenje pri dojenčkih in malčkih od starosti 6 tednov, proti davici, tetanus, oslovski kašelj, hepatitis b, otroški ohromelosti in invazivnih bolezni, ki povzroča haemophilus influenzae tipa b (hib). uporaba zdravila vaxelis mora biti v skladu z uradnimi priporočili.

Umoja wa Ulaya - Kislovenia - EMA (European Medicines Agency)

biogen idec ltd - daclizumab - multiple skleroza - imunosupresivi - zdravilo zinbryta je indicirano pri odraslih bolnikih za zdravljenje recidivnih oblik multiple skleroze (rms).

Slovenia - Kislovenia - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

vetconsult pharma -

Slovenia - Kislovenia - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

chanelle pharmaceuticals manufacturing ltd -

Slovenia - Kislovenia - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

gsk d.o.o., ljubljana - sumatriptan - raztopina za injiciranje - sumatriptan 6 mg / 0,5 ml - sumatriptan

Slovenia - Kislovenia - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

mcneil products limited, foundation park, roxborough way - cetirizin - kapsula, mehka - cetirizin 8,4 mg / 1 kapsula - cetirizin

Slovenia - Kislovenia - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

mcneil products limited, foundation park, roxborough way - minoksidil - dermalna pena - minoksidil 50 mg / 1 g - minoksidil

Slovenia - Kislovenia - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

mcneil products limited, foundation park, roxborough way - gvaifenezin - peroralna raztopina - gvaifenezin 20 ml / 1 ml - gvaifenezin

Slovenia - Kislovenia - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

hospira uk ltd. - meropenem - prašek za raztopino za injiciranje/infundiranje - meropenem 1000 mg / 1 viala - meropenem